Pramlintide structure
|
Common Name | Pramlintide | ||
---|---|---|---|---|
CAS Number | 151126-32-8 | Molecular Weight | 3949.43 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C171H269N51O53S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of PramlintidePramlintide is a polypeptide analogue of human amylin. Pramlintide is an antidiabetic, is antineoplastic in colorectal cancer[1]. |
Name | Pramlintide |
---|---|
Synonym | More Synonyms |
Description | Pramlintide is a polypeptide analogue of human amylin. Pramlintide is an antidiabetic, is antineoplastic in colorectal cancer[1]. |
---|---|
Related Catalog | |
In Vitro | Pramlintide inhibits the growth of HCT-116 and HT-29 in a dose-dependent manner, with higher efficacy against the latter (IC50s of 48.67 and 9.10 μg/mL, respectively)[1]. The addition of 5, 10, and 20 μg/mL of Pramlintide to HCT-116 and HT-29 with 5-fluorouracil, Oxaliplatin, or Irinotecan induces the antiproliferative effect synergistically[1]. |
References |
Molecular Formula | C171H269N51O53S2 |
---|---|
Molecular Weight | 3949.43 |
Storage condition | -20℃ |
Triproamylin |